BMA
ABBV icon

Brooks Moore & Associates’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.39M Buy
28,492
+149
+0.5% +$28.2K 2.91% 6
2025
Q1
$5.94M Sell
28,343
-200
-0.7% -$41.9K 3.35% 4
2024
Q4
$5.07M Hold
28,543
3% 7
2024
Q3
$5.64M Sell
28,543
-153
-0.5% -$30.2K 3.33% 5
2024
Q2
$4.92M Hold
28,696
3.17% 9
2024
Q1
$5.23M Sell
28,696
-85
-0.3% -$15.5K 3.35% 7
2023
Q4
$4.46M Sell
28,781
-200
-0.7% -$31K 3.07% 9
2023
Q3
$4.32M Sell
28,981
-1,349
-4% -$201K 3.26% 7
2023
Q2
$4.09M Sell
30,330
-488
-2% -$65.8K 2.88% 10
2023
Q1
$4.91M Buy
30,818
+585
+2% +$93.2K 3.53% 5
2022
Q4
$4.89M Sell
30,233
-6,713
-18% -$1.08M 3.57% 7
2022
Q3
$4.96M Buy
36,946
+892
+2% +$120K 4.01% 3
2022
Q2
$5.52M Sell
36,054
-1,534
-4% -$235K 3.98% 2
2022
Q1
$6.09M Sell
37,588
-2,800
-7% -$454K 3.74% 2
2021
Q4
$5.47M Buy
40,388
+1,060
+3% +$144K 3.21% 3
2021
Q3
$4.24M Sell
39,328
-4,645
-11% -$501K 2.78% 5
2021
Q2
$4.95M Sell
43,973
-375
-0.8% -$42.2K 3.16% 3
2021
Q1
$4.8M Buy
44,348
+2,375
+6% +$257K 3.25% 4
2020
Q4
$4.5M Buy
41,973
+2,066
+5% +$221K 3.48% 4
2020
Q3
$3.5M Buy
39,907
+6,719
+20% +$589K 3.01% 5
2020
Q2
$3.26M Buy
33,188
+2,371
+8% +$233K 3.05% 5
2020
Q1
$2.35M Buy
30,817
+2,110
+7% +$161K 2.49% 9
2019
Q4
$2.54M Buy
28,707
+1
+0% +$89 2.02% 15
2019
Q3
$2.17M Buy
28,706
+7,924
+38% +$600K 1.84% 19
2019
Q2
$1.51M Buy
20,782
+3,175
+18% +$231K 1.3% 29
2019
Q1
$1.42M Buy
17,607
+1,200
+7% +$96.7K 1.29% 31
2018
Q4
$1.51M Buy
+16,407
New +$1.51M 1.52% 24